Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach

Figure 2

Boxplots of biomarker levels of leukocyte counts (a), fibrinogen (b), C-reactive protein (c), myeloperoxidase (d), and ultrasensitive pregnancy-associated plasma protein A (e) at study inclusion and after 6-month followup. Statistical differences at 6-month followup were expressed as 𝑃<.05 (*) or 𝑃≤.001 (**).

(a)

(b)

(c)

(d)

(e)